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Abstract
Background: The relevance of discrete localization of hepatobiliary transporters in specific membrane microdomains is not well known. Aim: To
determine whether the Na+/taurocholate cotransporting polypeptide (Ntcp), the main hepatic sinusoidal bile salt transporter, is localized in specific
membrane microdomains. Methods: Presence of Ntcp in membrane rafts obtained from mouse liver was studied by immunoblotting and
immunofluorescence. HEK-293 cells stably transfected with rat Ntcp were used for in vitro studies. Expression, localization and function of Ntcp
in these cells were assessed by immunoblotting, immunofluorescence and biotinylation studies and Na+-dependent taurocholate uptake assays,
respectively. The effect of cholesterol depletion/repletion assays on Ntcp function was also investigated. Results: Ntcp localized primarily to
membrane rafts in in vivo studies and localized partially in membrane rafts in transfected HEK-293 cells. In these cells, membrane cholesterol
depletion resulted in a shift of Ntcp localization into non-membrane rafts, which correlated with a 2.5-fold increase in taurocholate transport.
Cholesterol repletion shifted back part of Ntcp into membrane rafts, and normalized taurocholate transport to values similar to control cells.
Conclusion: Ntcp localizes in membrane rafts and its localization and function are regulated by membrane cholesterol content. This may serve as a
novel regulatory mechanism of bile salt transport in liver.
© 2008 Elsevier B.V. All rights reserved.Keywords: Bile acid; Caveolin; Lipid microdomain; Lipid raft; Membrane transportTransport of bile salts (BS) by the hepatocytes is a vital
function of the liver since these amphipathic molecules are the
main driving force for bile secretion [1,2]. Handling of BS by liver
cells involves several steps: a) sinusoidal uptake fromportal blood
by the Sodium-Taurocholate Cotransporting Polypeptide (Ntcp,
Slc10a1) and members of the organic anion transporting
polypeptides (OATP's) family, b) transcellular translocation to
the canalicular membrane and c) active secretion into bile by the
bile salt export pump (BSEP, Abcb11) [3]. Regulatory mechan-
isms of BS transport have been described for all these steps andAbbreviations: BS, bile salts; BSEP, bile salt export pump; Cav-1, caveolin-1;
MR, membrane rafts; HEK 293, Human embryonic kidney 293; MCD, Methyl-β-
Cyclodextrin; Ntcp, Sodium-Taurocholate Cotransporting Polypeptide
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doi:10.1016/j.bbamem.2008.01.020include processes at both transcriptional and post-transcriptional
levels. The majority of the published data on this topic concern to
transcriptional control of hepatobiliary transporter genes and
come from experimental models for pathophysiological condi-
tions such as cholestasis [1,3]. Available data on post-transcrip-
tional regulation of BS transporters are less abundant [4–6].
Severalmechanisms have been described as being involved in this
type of regulation including covalent modifications (e.g.,
phosphorylation), substrate competition, and subcellular localiza-
tion related to rapid endo- or exocytosis of transporter-bearing
vesicles into and from the plasma membrane [6]. However,
additional molecular mechanisms may exist and need to be
characterized. Recent work has shown that the association of
certain hepatic transporters (e.g. aquaporins and the ABC
transporters P-Glycoprotein/Abcb1 and Breast Cancer Resistant
Protein, BCRP/Abcg2) to specific cholesterol/sphingolipids-rich
membrane domains may have functional consequences [7–9].
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(generically named membrane rafts [10]) has been matter of
controversy [11] the concept that membrane rafts are
implicated in a variety of cell functions including signal
transduction, protein sorting in polarized cells, apoptosis and
pathogen entry among others, is now widely accepted [12,13].
Most of the information on this topic has been generated using
two simple methods, the analysis of detergent resistance of
membranes and cholesterol depletion [12]. Thus, presence of a
given protein in detergent-resistant membranes and the fact that
cholesterol modulators affect its function in cells is consistent
with a role for rafts [12,14,15].
Data on membrane compartmentalization of BS transporters
and its potential functional importance is emerging. For example,
a recent paper by Annaba et al. [16] have shown that the ileal bile
acid transporter (ASBT, Slc10a2) is associated with lipid rafts
which have functional implications. Thus, the present study was
conducted to explore if Ntcp, the main sinusoidal hepatic BS
transporter [17] which has structural similarities with ASBT, is
also localized in membrane rafts in the liver and how this discrete
localization may influence its transport activity. Our results
indicate that in ex-vivo livers Ntcp localizes predominantly in
membrane rafts and that change in this localization in transfected
cells are associated with reciprocal changes in the function of this
BS transporter.
1. Materials and methods
1.1. Reagents, animals and cell lines
Unless otherwise stated, reagents were purchased from Sigma. C57BL6
mice (15–20 g body weight) were housed in transparent polycarbonate cages,
with wood chip bedding at a 12 h light/darkness cycle, a temperature of 21 °C,
and a relative humidity of 50% throughout the acclimatization (at least 1 week)
period and permitted ad libitum consumption of water. Animal experiments
were approved by the Local Ethics Review Committee on Animal Experiments
according to the criteria outlined in the “Guide for the Care and Use of
Laboratory Animals” prepared by the National Academy of Sciences and
published by the National Institutes of Health (NIH publication 86–23 revised
1985). Human embryonic kidney (HEK) 293 cell line (ATCC CRL 1573) that
was purchased from American Type Culture Collection (Manassas, VA) was
used in cell culture experiments.
1.2. Transfection of HEK293 cells with rat Ntcp
HEK-293 were grown in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin, 100 µg/ml streptomycin and 0.5 µg/ml fungizone at 37 °C with 5% de
CO2 and 95%humidity. Stable transfectionwith rat Ntcp [18]was achieved using a
pcDNA 3.1-Ntcp expression vector containing the full-length rat ntcp cDNA
(GenBank accession number NM_017047) using the Lipofectamine™ Reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer's suggested protocol.
Transfected cell lines were selected by growth with 800 µg/ml antibiotic G418
Sulfate and maintained with 400 µg/ml of the antibiotic G418 Sulfate (Geneticin)
(Life Technologies, Invitrogen, Carlsbad, CA). Ntcp transport function in HEK-
293-Ntcp cells was assessed by determining Na+-dependent taurocholate uptake as
previously described by us [19]. In these experiments choline was used as sodium
replacement and taurocholate uptakewas calculated as the difference betweenNa+-
containing and Na+-free buffers. Results were expressed as picomoles of TC per
milligram of protein. In selected experiments, HEK-293 cells were infected with
replication-defective adenoviral vectors carrying the full-length human caveolin-1
(Ad.Cav-1) as previously described by our laboratory [20].1.3. Confocal immunomicroscopy
Ntcp immunolocalization studies in mouse livers were performed as described
previously [20]. Briefly, livers were perfused via the portal vein with cold
phosphate-buffered saline and then excised and frozen under isopentane in liquid
nitrogen. Qualitative distribution of Ntcp and caveolin-1 was assessed by indirect
immunofluorescence using monoclonal anti-Cav-1 (clone 2297, dilution 1:100;
Transduction Laboratories, Cincinnati, OH) or anti-Ntcp [19]. Labeled sections
were examined on a Zeiss Axionplan microscope, and digital images were
processed using Axionvision imaging software (Carl Zeiss, Göttingen, Germany).
For cell culture experiments, indirect immunofluorescence microscopy was
performed on a confluent monolayer of transfected cells. The cells were fixed with
Paraformaldehyde and permeabilized with 0.2% v/v Triton X-100. Free aldehyde
groups were blocked with 50 mM NH4Cl. Nonspecific sites were blocked with
Gelatin Type Bloon 0.2% w/v diluted in PBS. Incubation with primary antibodies
for rat Ntcp, transferrin receptor (Tf-R) and caveolin-1 (Cav-1) was carried out for
2 h at 37 °C in a humid chamber. After washing with PBS 5 times for 5 min, cells
were incubated with secondary antibodies conjugated to FITC and rhodamine for
1 h, washed with 1× PBS and mounted in Fluoromount G (Electron Microscopy
Sciences, Hatfield, PA) for confocal microscope observation.
1.4. Isolation of membrane lipid microdomains
Membrane rafts were isolated using a flotation assay previously described by
Mora and coworkers [21]. Briefly, 200 mg of mice liver tissue was homogenized
in 1 ml of MBS buffer (MES 25 mM pH 6.5, NaCl 150 mM and PMSF 1 mM)
containing Triton X-100 (1% v/v) using a loose-fitting Dounce homogenizer (10
strokes on ice). Extraction was performed on ice for 30 min, and sucrose
concentration in samples was adjusted to 40% usingMBS containing 65% sucrose
w/w, overlaid with 1.3 ml of 30% and 1.3 ml of 5% sucrose/MBS and centrifuged
for 16–20 h at 200,000 ×g at 4 °C in a TST 60.4 rotor (Sorvall, Asheville, NC).
Membrane rafts were visible as an opalescent band at the 30%/5% interface of the
sucrose gradient. The total volume of the gradient was fractionated into twelve
tubes beginning with the top of the gradient.
Membrane raft isolation from HEK-293-Ntcp cells was carried out from
three confluent 150 mm dishes after washing with PBS. Cells were pelleted by
centrifugation at 80 ×g for 10 min and further scraped in 500 µl of MBS buffer
containing 1% Triton X-100 (v/v). The cells were homogenized in ice by 20
passages through a 25-gauge needle. After this step, the protocol for membrane
raft isolation was the same as that used for mouse liver tissue as described above.
1.5. Immunoisolation of caveolae from total hepatic lipid rafts
A procedure described by Stan et al. [22] with few modifications was used.
The membrane raft fractions isolated from the liver using Triton X-100 1% (3–
5 fractions) was diluted in 10 ml of MBS buffer and centrifuged at 100,000 ×g for
1 h to 4 °C in rotor T-875, the pellet obtained was resuspended in 1 ml of TNE
buffer (Tris–HCl 25 mM pH 7.5, NaCl 150 mM, EDTA 5 mM and PMSF 1 mM).
The samples were pre-cleared in 50 µl of Protein-A Sepharose for 1 h to 4 °C and
centrifuged at 280 ×g for 1 min. The pre-cleared samples were mixed with 2 µg of
monoclonal IgG2a anti Caveolin-1 (clone 2234, Transduction Labs) and incubated
for 1 h at 4 °C with constant rocking. The immunocomplexes were collected with
50 µl of Protein-A Sepharose by incubation for 1 h at 4 °C. The samples were
centrifuged at 280 ×g and the supernatant was recovered by pelleting to
100,000 ×g and stored in ice. The immunoprecipitates were washed three times
with TNE buffer and eluted by addition of 50 µl of Laemmli buffer and loaded
onto SDS-PAGE, after heating for 10 min at 37 °C and centrifugation at 5000 ×g.
The supernatant containing caveolae domains was loaded on SDS-PAGE together
with the same volume of non-caveolar membrane rafts and caveolae-containing
membrane raft samples used at the beginning of the protocol.
1.6. Extraction of lipid raft with different detergents
For these experiments the membrane rafts fractions of the sucrose gradient
(fractions 3 to 5) were diluted in 8 ml of TNE buffer (Tris–HCl 25 mM pH 7.5,
NaCl 150 mM, EDTA 5 mM and PMSF 1 mM) and centrifuged at 100,000 ×g in
a T-875 rotor for 1 h at 4 °C. The pellet containing membrane rafts were
Fig. 1. A: Cholesterol and protein content of fractions obtained from mouse liver
after Triton X-100 treatment and centrifugation in a sucrose gradient as described
in materials and methods. The Triton-insoluble, lipid-enriched microdomain
(lipid rafts) band (fractions 3 to 5) was located at the 5%/30% sucrose interface.
B: Representative immunoblot analysis of obtained fractions (numbers on the
top). The Sodium-Taurocholate Cotransporting Polypeptide (Ntcp) was detected
mainly in fractions 3–4 that also contain both caveolin-1 (Cav-1) and
glycosphingolipid GM1, known markers for lipid rafts. Clathrin and transferrin
receptor (Tf-R) were localized to the bottom of the gradient (fractions 8 to 12) in
the Triton-soluble fractions indicating that they reside in non-raft microdomains.
C: Representative western blots of Ntcp and Cav-1 using lipid rafts (fractions 3 to
5) treated with different detergents. I (insoluble) and S (soluble) indicate the two
fractions obtained after treatment. Chaps and octyl-β-D-glucoside (OG) only
marginally removes Cav-1 but does not remove Ntcp. In contrast, deoxycholic
acid (DCA) removed about half of the protein mass of Ntcp but does not remove
Cav-1. Treatment with Sodium dodecyl sulphate (SDS) removes both proteins
from the cholesterol-rich, detergent-resistant fractions. The different effects of
detergent treatment suggest that Ntcp and Cav-1 localize to different lipid
microdomains. Alternatively, the observed differences in this extraction
experiments could reflect the differences in the membrane attachment of Ntcp
and Cav-1 (see the text).
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30 min on ice with different detergents for each treatment (Chaps 20 mM, Octy-
β-glucosyde 60 mM, Deoxycholate 9 mM, SDS 1% as described previously
[23]. Lysates were centrifuged at 100,000 ×g for 1 h at 4 °C. The insoluble
fraction contained in the pellet was resuspended in 1 ml of TNE with the soluble
fraction remaining in the supernatant. Soluble and insoluble fractions were
subjected to immunoblot analysis as described below.
1.7. Treatment of Cells with Methyl-β-Cyclodextrin (MCD) and
cholesterol-MCD complexes
All experiments using cells were performed in serum-free DMEM as
described by Luker et al. [24]. In cholesterol depletion assays, cells were
incubated in 10 mM of MCD for 30 min to 37 °C. For cholesterol repletion
assays, cells were first treated with MCD, washed in PBS and incubated with
0.2 mM Cholesterol-MCD complex previously prepared as described by Klein
et al. [25] for 1 h to 37 °C. Control cells were incubated with medium alone.
After each treatment cells were washed three times with PBS and used for
experiments to measure taurocholate transport or isolation of membrane rafts
following immunoblot analysis.
Cell surface Biotinylation. These experiments were performed using sulfo-
NHSSS-biotin (0.5 mg/ml; Pierce, Rockford, IL) in an appropriate buffer (PBS/
CaMg (100 µM CaCl2 and 1 mM MgCl2), as previously described [26], with
labeling for 60 min under constant shaking at 4 °C to stop endocytosis and
internalization of antigens. The reaction was stopped adding 100 mM glycine in
PBS/CaMg for 10 m at 4 °C. After washing with PBS pH 7.4, cells were scraped
and centrifuged at 1000 rpm for 2 min and homogenized in 500 µl of TNE buffer
(Tris–HCl 25 mM pH 7.6, EDTA 5 mM, NaCl 150 mM, Triton X-100 1% v/v in
presence of protease inhibitors).After 30min in ice,membranemicrodomainswere
isolated using the flotation assay described above. 50 µl aliquots from fractions 3–5
(rafts) and fractions 9–12 (non-rafts) were diluted to 1 ml of TNE buffer and used
for immunoprecipitation of biotinylated antigens with streptavidin-agarose.
Immunoprecipitates were then subjected to SDS-PAGE and blots were probed
for Ntcp. To assess non-surface Ntcp content, 500 µl of supernatants were
precipitated with TCA and 25 µl of sample used for western blot experiments.
1.8. Immunoblotting
Samples were mixed with loading buffer of SDS-PAGE (5X) and heated for
5 min to 100 °C, except for immunoblotting of Ntcp. Proteins separated by the
gel were transferred into nitrocellulose membranes using Trans-blot system
(Bio-Rad Laboratories, Hercules, CA). Membranes were washed in TBS-T
(Tris–HCl 25 mM pH 7.5, NaCl 150 mM and Tween-20 0.05% v/v) and blocked
with 5% w/v of non-fat dry milk dissolved in TBS-T overnight to 4 °C. After
rinsing with TBS-T, membranes were incubated for 1.5 h with primary
antibodies in blocking buffer at room temperature. After this step, membranes
were rinsed three times and incubated for 1 h with secondary antibodies
conjugated to HRP. Following washing with TBS-T, blots of immunoreactive
complexes were visualized using the ECL™Western Blotting Detection System
(Amersham Biosciences (GE Healthcare, Piscataway, NJ).
1.9. Isolation of total membranes from HEK-293 cells
Confluent HEK-293 cells from one 100 mM dish were transfected with Ntcp
and wild-type cells were scraped in PBS and pelleted by centrifugation at 1,000 g
The cell pellet was resuspended in 1 ml of 25 mMTris–HCl pH 7.5, 2 mMMgCl2,
250 mM sucrose and 1 mM, PMSF, homogenized with 20 times on ice using tight-
dounce and centrifuged for 10min at 1000 ×g at 4 °C. The supernatant was pelleted
to 100,000 ×g for 1 h at 4 °C, the pellet containing total membranes was
resuspended in the homogenization buffer by 10 passages in ice through a 25G
needle. Protein content in this fraction was measured by Bradford method using
BSA as standard and stored at −80 °C.
1.10. Lipid extraction and free cholesterol measurements
Lipid extraction was carried out using 200 µl of each fraction of the gradient
or pooled fractions of membrane rafts and non- membrane rafts dissolved in
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chloroform, vortexed and incubated for 2 h at 4 °C and lipid phase was separated
by centrifugation at 1000 ×g for 10 min. The hydrophobic phase was obtained
and dried using N2. Lipids were resuspended in 100mMTris–HCl pH 7.6, 5 mM
phenol, aminoantiypirine and 0.2% v/v Triton X-100 in a bath sonicator. After
adding cholesterol oxidase and peroxidase to these samples, free cholesterol
content was measured at 500 nm using a standard technique.
1.11. Statistics
All results are expressed as mean±SE. A two-tailed non-paired Student's t-
test was used to compare differences between groups when appropriate. Values
were considered significantly different when the P value was equal to or less
than 0.05.2. Results
2.1. Ntcp localizes to membrane rafts of hepatic tissue
Triton X-100 lysates from mouse livers were separated on
discontinuous sucrose gradients and then characterized by immu-
noblotting with antibodies against specific proteins including Ntcp.
Twelve fractions (1 ml each) were collected from the bottom of the
gradient (fraction 1) to the top of the gradient (fraction 12). The
Triton-insoluble, lipid-enriched microdomain band (fractions 3
and 5) was located at the 5%/30% sucrose interface. Of note, only a
small proportion of total proteins are recovered in these fractions
while more than 50% of proteins were detected in the low-
cholesterol fractions (Fig. 1A). As shown in Fig. 1B, immunoblot
analysis of the different fractions revealed that most of the protein
mass of Ntcp was found in fractions 3–4 of the gradient that alsoFig. 2. The Sodium-Taurocholate Cotransporting Polypeptide (Ntcp) and Caveolin-1
from Lipid rafts fractions obtained from mouse liver, equal volumes of bound unboun
was found only in the unbound and total fractions suggesting that this transporter is pre
Ntcp in wild-type mouse liver. Livers from normal mice were stained for either Ntcp
with Alexa Fluor 488- (Molecular Probes, Inc., Eugene, OR) or Texas Red- (Kir
antibodies diluted at 1:400 and 1:100, respectively. A merged image is shown in thcontain bothCav-1 and glycosphingolipidGM1,which are positive
markers of membrane rafts. As expected, clathrin and Tf-R were
localized to the bottom of the gradient with Triton-soluble fractions
in agreement with previous reports showing that these proteins are
not associated with membrane rafts. Further studies using
additional treatment of the isolated membrane rafts with different
detergents showed that membrane rafts containing Ntcp differed
from those of Cav-1 in its insolubility/solubility properties. As
shown in Fig. 1C, deoxycholic acid (DCA) was able to remove
about half of the protein mass of Ntcp but did not remove Cav-1
suggesting that these proteins probably localize to different lipid
microdomains. Furthermore, treatment with the ionic detergent
SDS removes both proteins from the cholesterol-rich, detergent-
resistant fractions as previously described for other proteins
tightly-associated with membrane rafts [23]. Of note, the above
described experiments were also carried out with plasma
membrane fractions (data not shown) yielding similar results.
An alternate explanation to the observed differences in this
extraction experiments, is that the differences in the membrane
attachment of Ntcp and Cav-1, the former being a polytopic
integral membrane protein [17] and the latter being a non-
polytopic membrane protein that anchors to the membrane in a
hairpin configuration and interacts with itself to form homo-
oligomers [27,28], which determines its susceptibility to removal
by detergents.
Immunoisolation studies with specific antibodies for Cav-1
(Fig. 2A) revealed that Ntcp does not co-isolate with this protein,
which is in agreement with confocal immunofluorescence
studies in mouse liver (Fig. 2B). Collectively, these results
suggest that Ntcp isolated with membrane rafts is predominantly(Cav-1) do not colocalize in mouse liver. A: After immunoisolation of Cav-1
d and total Lipid rafts fractions were loaded and separated by SDS-PAGE. Ntcp
dominantly restricted to non-caveolar rafts. B: Immunolocalization of Cav-1 and
(left panel) or Cav-1 (middle panel). Bound primary antibodies were visualized
kegaard & Perry Laboratories Inc., Gaithersburg, MD) conjugated secondary
e right panel.
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membrane fraction.
2.2. Assessment of Ntcp expression, function and localization
in HEK-293 cells
As shown in Fig. 3A, HEK-293 cells stably transfected with
the full-length cDNA from rat Ntcp (HEK-293-Ntcp) expressed
this protein at similar levels to those observed in rat liver.
Functionality of the transporter was demonstrated by the
presence of Na+-dependent taurocholate uptake in HEK-293-
Ntcp cells [29.02±3 pmol min−1 mg protein−1 transfected cells
vs. 7.29±0.72 pmol min−1 mg protein−1 in non-transfected
cells, (n=3 each group, Pb0.05)]. Localization of Ntcp in
plasma membrane was assessed using double immunofluores-
cence labeling studies with antibodies against Ntcp and Cav-1.
As shown in Fig. 3B, Ntcp and Cav-1 do not colocalize in the
plasma membrane of HEK-293 cells expressing both cDNAs. In
addition, after isolation of membrane rafts from HEK-293-Ntcp
cells immunoblot analysis for Ntcp, Tf-R and Cav-1 was carriedFig. 3. Detection of the Sodium-Taurocholate Cotransporting Polypeptide (Ntcp) in
immunodetection of in wild-type (WT) HEK-293 and Ntcp-transfected HEK-293
immunofluorescence of Ntcp-transfected HEK-293 cells infected with an E1- and E3
caveolin-1 (Ad.Cav-1). Control adenovirus (Ad.ΔE1) contained the same E1 and E3
far right indicates a distinct localization of Ntcp and Cav-1 in doubly-transfected ceout to establish if Ntcp localizes to membrane rafts in HEK-293-
Ntcp cells. In these studies, Ntcp was detected in both membrane
rafts as well as non-rafts fractions (Fig. 4A). These results are
consistent with partial localization of Ntcp in non-caveolar
membrane rafts in these cells similar to that seen in mouse liver.
2.3. Effects of cholesterol depletion and repletion on Ntcp
localization and function in Ntcp-transfected HEK-293 cells
In order to assess if the association ofNtcpwithmembrane rafts
in liver tissue might have functional significance, we investigated
the effect of cholesterol depletion and repletion on both
localization of Ntcp in membrane rafts and sodium-dependent
taurocholate uptake in HEK-293-Ntcp cells. For that purpose,
cells were treated with either MCD or Cholesterol-MCD com-
plexes. As shown in Fig. 4A, MCD treatment was associated with
an 80% decrease in free cholesterol in membrane preparations of
HEK-293 cells while cholesterol re-loading with Cholesterol-
MCD complexes normalized cholesterol content. These changes
in cholesterol content were associated with modifications in NtcpNtcp-transfected HEK-293 cells. A: Representative western blot showing Ntcp
cells. A sample of a normal rat liver was used for comparison. B: Confocal
-deleted replication-defective adenoviral vectors carrying the full-length human
deletions without the transgene expression cassette. Merged image shown in the
lls.
Fig. 4. Effects of cholesterol depletion and repletion on membrane cholesterol content, Ntcp membrane localization and function in Ntcp-transfected HEK-293 cells. A:
MCD treatment was associated with an 80% decrease in free cholesterol in membrane preparations of HEK-293 cells while Cholesterol-MCD treatment normalized
cholesterol content in depleted cells. B: Representative western blots of the sodium-taurocholate cotransporting polypeptide (Ntcp), Cav-1 and transferrin receptor (Tf-R)
using fractions obtained fromHEK-293-Ntcp cells treatedwithMCDandCholesterol-MCDcomplexes after TritonX-100 treatment and centrifugation in a sucrose gradient,
as described in materials and methods. Ntcp abundance varies within membrane domains. While this transporter was localized to both lipid rafts and non-rafts fractions in
control cells, cholesterol depletion after MCD treatment determined a shift of Ntcp into non-rafts fractions (fractions 8–12), which is reversed by cholesterol repletion (re-
appearance of Ntcp in fraction 4). The impact of cholesterol alteration on Tf-R and Cav-1 localization was negligible since presence of these proteins in non-rafts and lipid
rafts fractions respectively remained unaffected by cholesterol manipulations. C: Changes in sodium-dependent uptake of taurocholate in Ntcp-transfected HEK-293 after
cholesterol depletion and repletion. A significant increase in the taurocholate uptake was observed after cholesterol depletion induced by MCD treatment. Restoration of
cellular cholesterol by the addition of cholesterol-MCD complexes to the depleted cells led to restoration of the transport function of Ntcp. D: Representative western blot
showing the effects of cholesterol depletion/repletion on surface localization of Ntcp in HEK-293-Ntcp cells. HEK-293-Ntcp cells were subjected to biotinylation at 4 °C
using sulfo-NHS-SS-biotin, lysed and surface biotinylated proteins were precipitated with streptavidin-agarose from equal amounts of total cellular protein. Precipitated
proteins (surface, S) and proteins in the supernatant (non-surface, NS) were separated on SDS-polyacrylamide gel electrophoresis and electroblotted to nitrocellulose blots.
Western blotting analysis was performedwith anti-Ntcp antibody. The relative abundance of Ntcp in the S andNS fractions obtained from control and treated cells (subjected
to cholesterol depletion/repletion) is shown in the Figure. Numbers refers to the ratio between the densitometric value of the respective band and that from the control cells.
Results displayed in graphs are presented as % of control values (for either cholesterol content or taurocholate uptake) and represent means±SE obtained from at least three
separate experiments. ⁎Pb0.05 or less compared to control.
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fact, Ntcp was localized to both membrane rafts and non-rafts
fractions in control cells (Fig. 4B, upper panel) and cholesterol
depletion resulted in a shift of Ntcp into non-rafts fractions
(Fig. 4B middle panel), which was partially reversed by cho-
lesterol repletion (Fig. 4B lower panel). The impact of changes
in plasma membrane cholesterol content on Tf-R and Cav-1
localization was negligible since presence of these proteins in
membrane rafts and non-rafts fractions respectively remainedunaffected after treatments with either MCD or cholesterol-
MCD complexes. These data indicate that these maneuvers
affect mainly fractions of membrane rafts containing Ntcp and
that Cav-1-containing membrane rafts or caveolae are highly
resistant to cholesterol depletion by MCD. Interestingly, changes
in plasma membrane cholesterol content of HEK-293-Ntcp cells
also correlated with significant changes in their sodium-
dependent uptake of taurocholate. Of note, as shown in Fig. 4C,
cholesterol depletion of HEK-293-Ntcp cells led to a significant
Fig. 5. Immunolocalization of Ntcp and Tf-R in Ntcp-transfected HEK-293 cells subjected to membrane cholesterol content manipulations. Under basal conditions,
Ntcp and Tf-R localized to the plasma membrane and also in intracellular compartments, with discrete co-localization only at the plasma membrane in some cells,
particularly those with higher expression levels. Cholesterol depleted cells showed an intensification of the signal for both proteins at the plasma membrane, with co-
localization of Ntcp and Tf-R at the cell surface but not intracellularly. Cholesterol repletion decreases the signal of both membrane proteins at the cell surface due to an
apparent internalization and dissociation of both proteins in intracellular compartments.
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and restoration of cellular cholesterol, by the addition of
cholesterol-MCD complexes to the depleted cells, restored
transport function of Ntcp to values similar to those seen in
control cells (Fig. 4C). Membrane biotinylation studies (Fig. 4D)
showed that the observed increase in transport activity after
cholesterol depletion was accompanied by a redistribution of Ntcp
protein between different membranemicrodomains (rafts and non-
rafts fractions) with no significant changes in the intracellular Ntcp
content.
Finally, in confocal immunomicroscopy studies (Fig. 5) we
observed that cholesterol depleted cells exhibited a stronger
plasma membrane signal and partial co-localization of Ntcp and
Tf-R which was reversed after cholesterol repletion due to the
apparent internalization of both proteins (Fig. 5).
3. Discussion
The aim of this study was to determine whether Ntcp, the
main BS importer of the hepatocyte, is localized in membrane
microdomains of hepatocytes and if this localization influences
its function. Our results indicate that Ntcp does localize mainly
in detergent-resistant fractions from the mouse liver (Fig. 1B),
namely membrane rafts [10]. Moreover, using Ntcp-transfected
cells, we found that changes Ntcp localization in the membrane
modifies sodium-dependent BS transport thus providing a novel
mechanism of regulation for this transporter.The presence of membrane rafts in the plasma membrane of
hepatocytes has been shown by several authors [7,29,30]. As
observed in other cell types, some membrane proteins are pre-
ferentially localized in detergent-resistant fraction domains [13].
For example, work from Mazzone et al. indicate that the water
channel aquaporin 8 is localized in these domains in addition to
other proteins involved in bile formation namely Anion exchanger
2 and multidrug resistant-associated protein 2 (Abcc2) [7]. Using
similar techniques, we found that Ntcp is also localized in mem-
brane rafts in the plasma membrane of mouse hepatocytes. In-
terestingly, this observation is in agreement with findings of a
recent study that characterized the membrane rafts proteome using
capillary liquid chromatography-tandem mass spectrometry and
identified Ntcp as one of the 196 proteins associated with mem-
brane rafts fractions isolated from rat liver [31]. In our experiments,
we confirmed that Ntcp localizes in specific membrane micro-
domains of mouse hepatocytes and further characterized the
association between Ntcp and membrane rafts treating these frac-
tions with different detergents and performing immunoisolation
studies as well as confocal immunofluorescence imaging. Col-
lectively, our results indicate that Ntcp is preferentially localized in
membrane rafts different from those where caveolin is
localized as is the case for other proteins such as the epidermal
growth factor (EGF) receptor, phosphatidylinositol 4-kinase,
phosphoinositides and GPI-linked proteins among others [32].
Association of membrane proteins with membrane rafts has
been related to a number of cellular processes including protein
1290 H. Molina et al. / Biochimica et Biophysica Acta 1778 (2008) 1283–1291sorting, signaling and protein functionality [12,33,34]. In the
case of membrane transporters, it has been shown that residency
in these membrane microdomains might be important for the
transport capacity as it has been described for the canalicular
ABC transporters P-glycoprotein/Abcb1 [8] and BCRP/Abcg2
[9], the HDL receptor, SR-BI [35] and more recently for the
ileal bile acid transporter ASBT, a symporter that belongs to the
same family as Ntcp [16,17]. Therefore, we wanted to study the
effects of altering the cholesterol concentration of the plasma
membrane, which should result in a shift of a substantial pro-
portion of Ntcp from membrane rafts to the detergent-soluble
membranes, and on Ntcp function. For these purposes, we
stably transfected with the full-length cDNA for rat Ntcp into
HEK-293 cells and assessed the sodium-dependent BS transport
using conventional techniques. Localizaion of Ntcp in trans-
fected cells was somewhat different to that observed in the
mouse liver with only part of Ntcp being found in membrane
rafts which may be due to different plasma membrane lipid
composition or due to overexpression of the transporter. How-
ever, as intended in these experiments, changes of the cho-
lesterol concentrations in these cells did result in a shift of Ntcp
from detergent-insoluble membranes to detergent-soluble parts
of the membrane and vice versa. Thus, while the shift of a
substantial portion of Ntcp to detergent-soluble parts of the
membrane in HEK-293-Ntcp was accompanied by a two-fold
increase in sodium-dependent BS uptake, shifting back Ntcp to
detergent-insoluble parts of the membrane was associated with
normalization of BS uptake. These findings strongly suggest
that changes in the lipid environment in which Ntcp is located
modulates its function. One possible explanation for this phe-
nomenon could be due to changes in plasma membrane fluidity.
Enhancement or reduction of transporter activity in response to
changes in plasma membrane fluidity has indeed been proposed
as important events in regulating BS transport in both sinusoidal
and canalicular domains of hepatocyte membrane [36,37].
Restoration of Ntcp transport function to control values after
increasing cellular cholesterol content by the addition of cho-
lesterol-MCD complexes to the depleted cells is consistent with
this concept. However, changes in membrane fluidity may not
be the only explanation for changes in transporter function since
it has been shown that decreasing cellular cholesterol and
disruption of membrane rafts do not affect transporter function
uniformly. In fact, the function of some hepatic transporters
decreased when translocated out of membrane rafts as is the
case of P-Glycoprotein [8,38] and ASBT [16]. Thus, additional
mechanisms should be considered. Since it has been found that,
in addition to plasma membrane, Ntcp also localizes to an
intracellular pool that serves as a reservoir from which they can
be recruited to the plasma membrane in response to an increased
transport demand (e.g. post-prandial period) [39–41], it is also
possible that depletion of cholesterol may induce changes in the
rafficking of Ntcp, to the cell surface. In our confocal im-
munomicroscopy studies (Fig. 5) we did observe that
cholesterol depleted cells exhibited a stronger plasma mem-
brane signal for Ntcp which was reversed after cholesterol
repletion due to the apparent internalization of the transporters.
Thus it could be speculated that cholesterol depletion mightpromote insertion of Ntcp through activation of this pathway.
However, this is not supported by our biotinylation studies. This
discrepancy may be related to technical issues and needs further
study.
In conclusion, our results indicate that Ntcp localizes
predominantly in non-caveolar membrane rafts in the liver and
that modifications in its membrane microdomain localization are
associated to reciprocal changes in the function of this BS
transporter. The importance of these findings for the regulation of
BS transport in the liver in both physiological and pathophysio-
logical conditions, such as cholestasis, deserves further study.
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